Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

NCT00504127 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1020

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Naproxcinod 375 mg bid
DRUG: Naproxcinod 750 mg bid
DRUG: Naproxen 500 mg bid
DRUG: placebo

Sponsor

NicOx